Published in Medicine and Law Weekly, April 24th, 2009
This prospective purchase is the second planned acquisition this year, representing an integral component of Migami’s strategic efforts concerning the acquisition and scaling out of proprietary, drug-delivery systems and global GMP-manufacturing capability. This acquisition is intended to bring...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly